Literature DB >> 17409784

Upper lateral cartilage inner mucoperichondrial flap technique for the repair of nasal septal perforation.

Alper Ceylan1, Fikret Ileri, Fatih Celenk, Metin Yilmaz, Sabri Uslu.   

Abstract

Treatment of nasal septal perforations which decrease quality of life is a surgical challenge with variable success rates. Numerous surgical methods have been proposed for closure of perforations. The technique described in this article, i.e. closure of the perforation with an upper lateral cartilage mucoperichondrial flap through an external septorhinoplasty approach, is an alternative surgical technique. Twenty-four patients with symptomatic nasal septal perforation were operated on using this technique and followed up for a mean duration of 28 months. Preoperative and postoperative symptom scores for crusting, nasal obstruction, bleeding, discharge, whistling, headache, nasal pain, snoring and olfactory loss as well as overall discomfort levels were compared using a visual analogue scale. Complete closure of the perforation was achieved in 19 patients. Copyright (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2007        PMID: 17409784     DOI: 10.1159/000101546

Source DB:  PubMed          Journal:  ORL J Otorhinolaryngol Relat Spec        ISSN: 0301-1569            Impact factor:   1.538


  3 in total

1.  Temporoparietal Fascia Free Flap for Nasoseptal Perforation Repair.

Authors:  Samuel Helman; Sameep Kadakia; Ashley Guthrie; Moustafa Mourad; Grigoriy Mashkevich
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2017-08-25

2.  The reconstruction of nasal septal perforation with high density porous polyethylene covered with fascia lata: an experimental study on rabbit model.

Authors:  Güven Yildirim; Vedat Onar; Ibrahim Sayin; Suzan Deniz Onol; Tamer Aydin
Journal:  Clin Exp Otorhinolaryngol       Date:  2011-09-06       Impact factor: 3.372

Review 3.  Endoscopic repair of nasal septal perforation.

Authors:  M Cassano
Journal:  Acta Otorhinolaryngol Ital       Date:  2017-12       Impact factor: 2.124

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.